Medical Properties Trust vs Starwood Property Trust
MPT and STWD side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MPT and STWD compare
Starwood Property Trust is the larger company, worth 4.4 times as much as Medical Properties Trust ($4.2B against $950M).
Starwood Property Trust grew revenue faster over the last twelve months (11.8% versus 10.6% for Medical Properties Trust).
Starwood Property Trust keeps more of each dollar of sales as profit, with a net margin of 11.4% compared with −3.0% at Medical Properties Trust.
Both pay dividends: Medical Properties Trust yields 22.6% and Starwood Property Trust 17.0%.
Starwood Property Trust scores higher on the StockData Score (14 against 9 for Medical Properties Trust), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MPT | STWD |
|---|---|---|
| Size and price | ||
| Market cap | $950M | $4.2B |
| Share price | $1.59 | $11.32 |
| Change, 1 year | −67.9% | −36.5% |
| Change, 5 years | −92.6% | −55.9% |
| Beta (5Y) | 1.60 | 0.23 |
| Employees | 121 | 324 |
| StockData Score | ||
| Total score | 9 | 14 (better) |
| Valuation score | 4 (better) | 3 |
| Growth score | 1 | 1 |
| Performance score | 1 | 2 (better) |
| Health score | 0 | 4 (better) |
| Dividend score | 3 | 4 (better) |
| Valuation | ||
| P/E | – | 19.2× |
| P/S | 0.9× (better) | 2.1× |
| P/B | 0.2× (better) | 0.6× |
| EV/EBITDA | 0.7× (better) | 9.8× |
| Fair value | $7.88 | $13.84 |
| Margin of safety | 79.8% (better) | 18.2% |
| Growth | ||
| Revenue growth (TTM) | 10.6% | 11.8% (better) |
| Revenue growth, 5Y average | −4.9% | 10.2% (better) |
| Net income growth (TTM) | – | −38.4% |
| EPS growth (TTM) | – | −45.9% |
| EPS growth, 5Y average | – | −0.17% |
| Profitability | ||
| Net margin | −3.0% | 11.4% (better) |
| Return on equity | −0.65% | 3.5% (better) |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Altman Z-score | −0.28 | 0.07 (better) |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 22.6% (better) | 17.0% |
| Payout ratio | – | 307% |
| Years of dividend growth | 0 | 0 |
| Dividend growth, 5Y average | −21.4% | 0.00% (better) |
| Buyback yield | – | −12.8% |
| Shareholder yield | 22.6% (better) | 4.1% |
| Ownership | ||
| Held by institutions | 61.1% | 50.3% |
| Held by insiders | 2.2% | 6.3% |
| Insider net buying, 12 months | −$455 | $16.6M (better) |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 25.5% | 5.8% |
Go deeper
- MPT stock overview
- MPT income statement
- MPT valuation and score
- STWD stock overview
- STWD income statement
- STWD valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.